Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease

NCT01108978 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Cardiovascular Disease
Hypercholesterolemia

Interventions

DRUG: Placebo
DRUG: Dehypotin

Sponsor

Nang Kuang Pharmaceutical Co., Ltd.

Collaborators

[object Object]